Hochschulschrift
Design of peptidomimetics towards new foldamers and 26S proteasome inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
194 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Regensburg, Univ., Diss., 2008 und Paris, Univ. Paris-Sud 11, Diss., 2008
- Schlagwort
-
Naturstoff
Polymere
Makromolekulare Chemie
Makromolekül
Zwischenmolekulare Kraft
Supramolekulare Chemie
Coenzym
Enzymologie
Cofaktor
Enzym
- Urheber
-
Formicola, Lucia
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:06 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Formicola, Lucia
Ähnliche Objekte (12)
Design of peptidomimetics towards new foldamers and 26S proteasome inhibitors
Design, synthesis and structural evaluation of peptidomimetics towards foldamers, PNAs and non covalent inhibitors of the 20S proteasome
Characterisation and optimisation of 20S proteasome inhibitors
Characterisation and optimisation of 20S proteasome inhibitors
Immunomodulatory activity of HDAC and proteasome inhibitors in inflammation and carcinogenesis
Studies on the trypanocidal activities of cysteine proteinase and proteasome inhibitors
Synthesis and biological evaluation of β-secretase [beta-secretase] inhibitors, proteasome inhibitors and Losartan active metabolites
Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A
Aminocoumarins and epoxyketone proteasome inhibitors from actinomycetes : characterization, heterologous expression and biosynthesis
Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A
The Proteasome, a New Target for Cancer Therapy
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity
Design of peptidomimetics towards new foldamers and 26S proteasome inhibitors
Design, synthesis and structural evaluation of peptidomimetics towards foldamers, PNAs and non covalent inhibitors of the 20S proteasome
Characterisation and optimisation of 20S proteasome inhibitors
Characterisation and optimisation of 20S proteasome inhibitors
Immunomodulatory activity of HDAC and proteasome inhibitors in inflammation and carcinogenesis
Studies on the trypanocidal activities of cysteine proteinase and proteasome inhibitors
Synthesis and biological evaluation of β-secretase [beta-secretase] inhibitors, proteasome inhibitors and Losartan active metabolites
Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A
Aminocoumarins and epoxyketone proteasome inhibitors from actinomycetes : characterization, heterologous expression and biosynthesis
Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A
The Proteasome, a New Target for Cancer Therapy
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity
Design of peptidomimetics towards new foldamers and 26S proteasome inhibitors
Design, synthesis and structural evaluation of peptidomimetics towards foldamers, PNAs and non covalent inhibitors of the 20S proteasome
Characterisation and optimisation of 20S proteasome inhibitors
Characterisation and optimisation of 20S proteasome inhibitors
Immunomodulatory activity of HDAC and proteasome inhibitors in inflammation and carcinogenesis
Studies on the trypanocidal activities of cysteine proteinase and proteasome inhibitors
Synthesis and biological evaluation of β-secretase [beta-secretase] inhibitors, proteasome inhibitors and Losartan active metabolites
Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A
Aminocoumarins and epoxyketone proteasome inhibitors from actinomycetes : characterization, heterologous expression and biosynthesis
Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A
The Proteasome, a New Target for Cancer Therapy